Introduction Hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NA) are standard prophylaxis against hepatitis B ...
With great interest we read the work by Talley et al 1 reporting the inadequacy of zonulin as a biomarker due to its failure to identify the irritable bowel syndrome, functional dyspepsia and ...
Background While Alistipes putredinis (AP) abundance in the faeces of patients with inflammatory bowel disease (IBD) decreases, its role in IBD is not well understood. We, therefore, investigated the ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
In a group of 181 persons with a past history of chronic gastric ulcer, a greatly increased incidence of domestic and financial stress has been found, when compared with age-and sex-matched persons ...
Background Small intestinal bacterial overgrowth (SIBO) is a clinical syndrome with abdominal complaints and malabsorption. Despite concerns over cure rates, recurrence, and antibiotic resistance, ...
Background Endoscopic variceal ligation (EVL) and endoscopic injection sclerotherapy (EIS) can be effectively used for acute esophageal variceal bleeding (AEVB) in cirrhosis. Current practice ...
Prof. Dr C H C M Buys, Department of Medical Genetics, University of Groningen, A. Deusinglaan 4, NL-9713 AW Groningen, The Netherlands. Background—Germline mutations of the RET proto-oncogene ...
Objective: To investigate differential intestinal gene expression in patients with ulcerative colitis and in controls. Design: Genome-wide expression study (41 058 expression sequence tags, 215 ...
Fibroblast growth factor 21 (FGF21) is a master regulator of metabolism associated with positive outcomes in a variety of metabolic disorders including metabolic-dysfunction associated steatohepatitis ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...